Design, Synthesis, and Biological Evaluation of Coumarin Derivatives Tethered to an Edrophonium-like Fragment as Highly Potent and Selective Dual Binding Site Acetylcholinesterase Inhibitors

被引:72
作者
Pisani, Leonardo [1 ]
Catto, Marco [1 ]
Giangreco, Ilenia [1 ]
Leonetti, Francesco [1 ]
Nicolotti, Orazio [1 ]
Stefanachi, Angela [1 ]
Cellamare, Saverio [1 ]
Carotti, Angelo [1 ]
机构
[1] Univ Bari Aldo Moro, Dipartimento Farmacochim, I-70125 Bari, Italy
关键词
acetylcholinesterase; Alzheimer's disease; coumarin derivatives; glaucoma; inhibitors; BETA-AMYLOID AGGREGATION; TARGET-DIRECTED LIGANDS; ALZHEIMERS-DISEASE; HYBRIDS; DOCKING; MECHANISMS; STRATEGIES; HUPERZINE; DONEPEZIL; DEMENTIA;
D O I
10.1002/cmdc.201000210
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
A large series of substituted coumarins linked through an appropriate spacer to 3-hydroxy-N,N-dimethylanilino or 3-hydroxy-N, N,N-trialkylbenzaminium moieties were synthesized and evaluated as acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitors. The highest AChE inhibitory potency in the 3-hydroxy-N, N-dimethylanilino series was observed with a 6,7-dimethoxy-3-substituted coumarin derivative, which, along with an outstanding affinity (IC50 = 0.236 nm) exhibits excellent AChE/BChE selectivity (SI > 300 000). Most of the synthesized 3-hydroxy-N, N, N-trialkylbenzaminium salts display an AChE affinity in the sub-nanomolar to picomolar range along with excellent AChE/BChE selectivities (SI values up to 138 333). The combined use of docking and molecular dynamics simulations permitted us to shed light on the observed structure-affinity and structure-selectivity relationships, to detect two possible alternative binding modes, and to assess the critical role of pi-pi stacking interactions in the AChE peripheral binding site.
引用
收藏
页码:1616 / 1630
页数:15
相关论文
共 69 条
[1]
Predicting relative binding free energies of tacrine-huperzine A hybrids as inhibitors of acetylcholinesterase [J].
Barril, X ;
Orozco, M ;
Luque, FJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (25) :5110-5119
[2]
The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[3]
MTDL Design Strategy in the Context of Alzheimer's Disease: From Lipocrine to Memoquin and Beyond [J].
Bolognesi, M. L. ;
Rosini, M. ;
Andrisano, V. ;
Bartolini, M. ;
Minarini, A. ;
Tumiatti, V. ;
Melchiorre, C. .
CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (06) :601-613
[4]
Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase [J].
Brühlmann, C ;
Ooms, F ;
Carrupt, PA ;
Testa, B ;
Catto, M ;
Leonetti, F ;
Altomare, C ;
Carotti, A .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (19) :3195-3198
[5]
Pharmacogenomics and therapeutic strategies for dementia [J].
Cacabelos, Ramon .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2009, 9 (06) :567-611
[6]
Camps P., 2001, Mini-Reviews in Medicinal Chemistry, V1, P163, DOI 10.2174/1389557013406972
[7]
Evaluation of short-tether bis-THA AChE inhibitors. A further test of the dual binding site hypothesis [J].
Carlier, PR ;
Han, YF ;
Chow, ESH ;
Li, CPL ;
Wang, H ;
Lieu, TX ;
Wong, HS ;
Pang, YP .
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (02) :351-357
[8]
CAROTTI A, 2007, ACS EFMC M FRONT CNS
[9]
Case DA., 2008, AMBER 10 University of California
[10]
Multi-target-directed ligands to combat neurodegenerative diseases [J].
Cavalli, Andrea ;
Bolognesi, Maria Laura ;
Minarini, Anna ;
Rosini, Michela ;
Tumiatti, Vincenzo ;
Recanatini, Maurizio ;
Melchiorre, Carlo .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (03) :347-372